Sunday - December 22, 2024

High Affinity Human Antibodies to Human IL-4 Receptor

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12162943 B2, initially filed Oct. 6, 2020) developed by five inventors Joel H. Martin, Putnam Valley, New York; Tammy T. Huang, Golden Bridge, New York; Jeanette L. Fairhurst, White Plains, New York; Nicholas J. Papadopoulos, LaGrangeville, New York; and George D. Yancopoulos, Yorktown Heights, New York, for "High affinity human antibodies to human IL-4 receptor." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

High Affinity Human Antibodies to Human IL-4 Receptor

Information Request Form

Copyright Targeted News Service 2024